Executive Departure	3 Months Ended
Dec. 29, 2012
Executive Departure	(18) Executive Departure On January 22, 2013, the Company announced that Carl Hull will be retiring from his role as Senior Vice President and General Manager of Diagnostics. Mr. Hull, who served as Chairman, President and Chief Executive Officer of Gen-Probe until it was acquired by Hologic in August 2012, will continue with the Company as a consultant up to mid-August 2013. As a result, the Company expects to record a charge of approximately $6.5 million in the second quarter of fiscal 2013 related to the acceleration of certain retention payments and equity awards pursuant to the original terms of the related agreements.

(18) Executive Departure

On January 22, 2013, the Company announced that Carl Hull will be retiring from his role as Senior Vice President and General Manager of Diagnostics. Mr. Hull, who served as Chairman, President and Chief Executive Officer of Gen-Probe until it was acquired by Hologic in August 2012, will continue with the Company as a consultant up to mid-August 2013. As a result, the Company expects to record a charge of approximately $6.5 million in the second quarter of fiscal 2013 related to the acceleration of certain retention payments and equity awards pursuant to the original terms of the related agreements.